7 completed. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 7 |
| Phase 2 | 1 | Completed 1 |
Follow Estrogen Replacement Therapy: new trials by email Literature Review of Estrogen Replacement Therapy trials Research Report on Estrogen Replacement Therapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Alzheimer's Disease: Therapeutic Potential of Estrogen Transdermal estradiol, Medroxyprogesterone, Placebo Patch - Alzheimer Disease | Phase 2 / Phase 3 | Completed | University of Wisconsin, Madison | 42 | 2001-09-01 | 2018-08-23 |
| Women's Angiographic Vitamin and Estrogen Trial (WAVE) estrogen replacement therapy, estrogens, conjugated, progesterone - Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1996-08-01 | 2016-07-12 | |
| Postmenopausal Hormone Therapy in Unstable Angina estrogen replacement therapy, estrogens, progesterone - Angina, Unstable, Cardiovascular Diseases | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1995-07-01 | 2016-02-18 | |
| Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART) estrogen replacement therapy, hormone replacement therapy, estradiol - Cardiovascular Diseases, Coronary Disease | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1995-03-01 | 2016-07-12 | |
| Estrogen Replacement and Atherosclerosis (ERA) in Older Women estrogen replacement therapy, hormone replacement therapy, estrogens - Cardiovascular Diseases, Coronary Arteriosclerosis | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1994-08-01 | 2016-03-16 | |
| Postmenopausal Estrogen/Progestin Interventions (PEPI) estrogens, conjugated, medroxyprogesterone, progesterone - Bone Diseases, Cardiovascular Diseases | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1987-09-01 | 2016-05-13 | |
| Women's Health Initiative (WHI) hormone replacement therapy, estrogens, progestins - Bone Diseases, Breast Neoplasms | Phase 3 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 2016-04-15 |
Cardiovascular Diseases (6) · Coronary Disease (6) · Heart Diseases (6) · Myocardial Ischemia (5) · Bone Diseases (2) · Coronary Artery Disease (2) · Osteoporosis (2) · Alzheimer Disease (1) · Angina, Unstable (1) · Breast Neoplasms (1) · Colonic Neoplasms (1) · Diabetes Mellitus (1) · Hypercholesterolemia (1) · Hypertension (1) · Thrombosis (1)
National Heart, Lung, and Blood Institute (NHLBI) (6) · University of Wisconsin, Madison (1)
United States (1)
David Herrington (1) · Howard Hodis (1) · Joel Verter (1) · Mark Espeland (1) · Ross Prentice (1) · Sanjay Asthana, MD (1)
PMID 16467232, PMID 16467233, PMID 16467234, PMID 16481635, PMID 16481636, PMID 16609086, PMID 16880313, PMID 17329508, PMID 17341712, PMID 17405972, PMID 17502530, PMID 17582069, PMID 17925539, PMID 18235052, PMID 18299491, PMID 18319414, PMID 18489937, PMID 18502208, PMID 18663162, PMID 19001202, PMID 19005970, PMID 19193613, PMID 19204221, PMID 19221190, PMID 19402886, PMID 19403636, PMID 19423530, PMID 19474140, PMID 19767090, PMID 19822825, PMID 19861516, PMID 20056625, PMID 20157135, PMID 20160160, PMID 20181812, PMID 20354566, PMID 20433539, PMID 20667078, PMID 20833684, PMID 20884191, PMID 20937929, PMID 20959578, PMID 20980487, PMID 21177798, PMID 21416508, PMID 21467283, PMID 21525191, PMID 21562091, PMID 21613558, PMID 21669380
N01HV68165 (1), N01HV68166 (1), N01HV68167 (1), N01HV68168 (1), N01HV68169 (1), N01HV68170 (1), R01AG017196 (1), R01HL050839 (1), U01HL040232 (1), U01HL049488 (1)